The orphan nuclear receptor Rev-erbα: A transcriptional link between circadian rhythmicity and cardiometabolic disease

Current Opinion in Lipidology

Volumn 18, Issue 2, 2007, Pages 141-146

  Fontaine, Coralie ^a   Staels, Bart ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Cardiovascular disease; Circadian rhythm; Metabolic syndrome; Nuclear receptors; Rev erb

Indexed keywords

CELL NUCLEUS RECEPTOR; HYDROCORTISONE; MELATONIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CLOCK; TRANSCRIPTION FACTOR REV ERBALPHA; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; DIABETES MELLITUS; DYSLIPIDEMIA; FATTY LIVER; GENE EXPRESSION; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; LIGAND BINDING; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; MOLECULAR MODEL; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; DNA-BINDING PROTEINS; HEART DISEASES; HUMANS; METABOLIC DISEASES; MICE; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 33947168323     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3280464ef6     Document Type: Review

References (59)

1. Gachon F, Nagoshi E, Brown SA, et al. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004; 113:103-112.
2. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987; 75:131-138.
3. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:1315-1322.
4. Staels B. When the Clock stops ticking, metabolic syndrome explodes. Nat Med 2006; 12:54-55; discussion 55.
5. Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002; 110:251-260.
6. Migita H, Morser J, Kawai K. Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells. FEBS Lett 2004; 561:69-74.
7. Raspe E, Duez H, Mansen A, et al. Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription. J Lipid Res 2002; 43:2172-2179.
8. Fontaine C, Dubois G, Duguay Y, et al. The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. J Biol Chem 2003; 278:37672-37680.
9. Pircher P, Chomez P, Yu F, et al. Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbAalpha orphan receptor gene. Am J Physiol Regul Integr Comp Physiol 2005; 288:R482-R490.
10. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell 2002; 111:919-922.
11. Bunger MK, Wilsbacher LD, Moran SM, et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000; 103:1009-1017.
12. Antoch MP, Song EJ, Chang AM, et al. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 1997; 89:655-667.
13. Chawla A, Lazar MA. Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. J Biol Chem 1993; 268:16265-16269.
14. Forman BM, Chen J, Blumberg B, et al. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol 1994; 8:1253-1261.
15. Munroe SH, Lazar MA. Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA. J Biol Chem 1991; 266:22083-22086.
16. Onishi H, Yamaguchi S, Yagita K, et al. Rev-erbalpha gene expression in the mouse brain with special emphasis on its circadian profiles in the suprachiasmatic nucleus. J Neurosci Res 2002; 68:551-557.
17. Torra IP, Tsibulsky V, Delaunay F, et al. Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver. Endocrinology 2000; 141:3799-3806.
18. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998; 93:929-937.
19. Zvonic S, Ptitsyn AA, Conrad SA, et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 2006; 55:962-970. • This study reinforced the importance of peripheral circadian rhythm and its potential therapeutic relevance with respect to the pathogenesis and treatment of diseases linked to the metabolic syndrome.
20. Renaud JP, Harris JM, Downes M, et al. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. Mol Endocrinol 2000; 14:700-717.
21. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006; 311:1002-1005. •• The authors demonstrate that glycogen synthase kinase phosphorylates and stabilizes Rev-erbα. They show that posttranslational regulation of Rev-erbα plays a role in the control of circadian rhythmicity.
22. Harding HP, Lazar MA. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol 1995; 15:4791-4802.
23. Raspe E, Mautino G, Duval C, et al. Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha. J Biol Chem 2002; 277:49275-49281.
24. Adelmant G, Begue A, Stehelin D, Laudet V. A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc Natl Acad Sci U S A 1996; 93:3553-3558.
25. Albrecht U. Molecular orchestration of the hepatic circadian symphony. Genome Biol 2006; 7:234.
26. Ando H, Yanagihara H, Hayashi Y, et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005; 146:5631-5636.
27. Block G. Keep time, stay healthy. Sci Aging Knowledge Environ 2005; 2005:pe13.
28. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005; 308:1043-1045. •• Using animal models in which Clock genes are invalidated, these two studies demonstrate that circadian rhythm disorders are associated with diabetes, obesity, and cardiovascular risk.
29. Williams DL, Schwartz MW. Out of synch: Clock mutation causes obesity in mice. Cell Metab 2005; 1:355-356. •• Using animal models in which Clock genes are invalidated, these two studies demonstrate that circadian rhythm disorders are associated with diabetes, obesity, and cardiovascular risk.
30. Rudic RD, McNamara P, Curtis AM, et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004; 2:e377.
31. Sacks FM, Alaupovic P, Moye LA, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 2000; 102:1886-1892.
32. Raspe E, Duez H, Gervois P, et al. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem 2001; 276:2865-2871.
33. Vu-Dac N, Chopin-Delannoy S, Gervois P, et al. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem 1998; 273:25713-25720.
34. Vu-Dac N, Gervois P, Grotzinger T, et al. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J Biol Chem 1997; 272:22401-22404.
35. Lusis AJ. Atherosclerosis. Nature 2000; 407:233-241.
36. Barish GD, Downes M, Alaynick WA, et al. A Nuclear Receptor Atlas: macrophage activation. Mol Endocrinol 2005; 19:2466-2477.
37. Teboul M, Barrat-Petit MA, Li XM, et al. Atypical patterns of circadian clock gene expression in human peripheral blood mononuclear cells. J Mol Med 2005; 83:693-699.
38. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004; 26:89-93.
39. Delerive P, Monte D, Dubois G, et al. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep 2001; 2:42-48.
40. Besnard S, Heymes C, Merval R, et al. Expression and regulation of the nuclear receptor RORalpha in human vascular cells. FEBS Lett 2002; 511:36-40.
41. Migita H, Satozawa N, Lin JH, et al. RORalpha1 and RORalpha4 suppress TNF-alpha-induced VCAM-1 and ICAM-1 expression in human endothelial cells. FEBS Lett 2004; 557:269-274.
42. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3:1879-1883.
43. Wang J, Yin L, Lazar MA. The orphan nuclear receptor REV-ERBalpha regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem 2006; 281:33842-33848. •• The authors provide one plausible molecular link between the morning susceptibility to myocardial infarction and Rev-erba. In addition, they show another example of crosstalk between Rev-erba and RORa on a common target gene.
44. Hermann C, von Aulock S, Dehus O, et al. Endogenous cortisol determines the circadian rhythm of lipopolysaccharide - but not lipoteichoic acid-inducible cytokine release. Eur J Immunol 2006; 36:371-379.
45. Koyanagi S, Okazawa S, Kuramoto Y, et al. Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues. Mol Endocrinol 2006; 20:573-583.
46. Frederic F, Chianale C, Oliver C, Mariani J. Enhanced endocrine response to novel environment stress and lack of corticosterone circadian rhythm in staggerer (Rora sg/sg) mutant mice. J Neurosci Res 2006; 83:1525-1532.
47. Sato TK, Panda S, Miraglia LJ, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004; 43:527-537.
48. Guillaumond F, Dardente H, Giguere V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005; 20:391-403. • In this study, cross-talk between all the members of the Rev-erb and ROR family was illustrated by studying Bmal1 transcription. These nuclear receptors recognize the same response element in the promoter of the Bmal1 gene but exert opposite effects on its transcription. This cross-talk suggests a fine-tuned regulation of Bmal1 gene expression and indicates that all members of the Rev-erb and ROR families are crucial components of the molecular circadian clock.
49. Touitou Y, Bogdan A. Promoting adjustment of the sleep-wake cycle by chronobiotics. Physiol Behav 2006; Oct 19; [Epub ahead of print].
50. Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15:432-437.
51. Derlacz RA, Poplawski P, Napierala M, et al. Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules. J Pineal Res 2005; 38:164-169.
52. Winiarska K, Fraczyk T, Malinska D, et al. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 2006; 40:168-176.
53. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006; 119:898-902.
54. Agez L, Laurent V, Pevet P, et al. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 2007; 144:522-530.
55. Pevet P, Agez L, Bothorel B, et al. Melatonin in the multioscillatory mammalian circadian world. Chronobiol Int 2006; 23:39-51.
56. Wiesenberg I, Missbach M, Carlberg C. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998; 12:143-150.
57. Gervois P, Chopin-Delannoy S, Fadel A, et al. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element. Mol Endocrinol 1999; 13:400-409.
58. Kassam A, Capone JP, Rachubinski RA. Orphan nuclear hormone receptor RevErbalpha modulates expression from the promoter of the hydratase- dehydrogenase gene by inhibiting peroxisome proliferator-activated receptor alpha-dependent transactivation. J Biol Chem 1999; 274:22895-22900.
59. Hsu MH, Palmer CN, Song W, et al. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J Biol Chem 1998; 273:27988-27997.